NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

NCT01726452 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

NETWORK

Sponsor class

Conditions

Adenocarcinoma of the Oesophagus
Adenocarcinoma of the Oesophago-gastric Junction
Oesophageal Tumours
Junctional Tumours
Oesophageal Cancer

Interventions

DRUG: Epirubicin
DRUG: Cisplatin / Oxaliplatin
DRUG: 5 Flourouracil/ Capecitabine
RADIATION: (41.4 Gy/23 fractions)
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Docetaxel
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: 5-Fluorouracil

Sponsor

Cancer Trials Ireland

Collaborators

[object Object]
[object Object]
[object Object]